| Home | E-Submission | Sitemap | Editorial Office |  
top_img
      
REVIEW ARTICLE 2019 May 3
Autoimmune Diseases and Gastric Cancer Risk: A Systematic Review and Meta-Analysis
Purpose Autoimmunity is an alternative etiology of gastric inflammation, the initiating event in the gastric carcinogenic cascade. This mechanism may be an increasingly important cause of gastric cancer with the waning prevalence of its primary etiologic factor, chronic Helicob...
SPECIAL ARTICLE 2019 June 7
Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients
Purpose A cross-sectional survey was conducted to explore the current awareness and use of complementary and alternative medicine (CAM), as well as attitudes toward CAM, in patients with cancer and their family members in South Korea. Materials and Methods Between September 2...
ORIGINAL ARTICLE 2018 October 1
A Phage Display-Identified Peptide Selectively Binds to Kidney Injury Molecule-1 (KIM-1) and Detects KIM-1-Overexpressing Tumors in vivo
Purpose This study was carried out to identify a peptide that selectively binds to kidney injury molecule-1 (KIM-1) by screening a phage-displayed peptide library and to use the peptide for the detection of KIM-1overexpressing tumors in vivo. Materials and Methods Biopanning ...
ORIGINAL ARTICLE 2018 October 2
Retrospective Study of the Significant Predictive Role of Inflammatory Degree in Initial and Repeat Prostate Biopsy Specimens for Detecting Prostate Cancer
Purpose The purpose of this study was to determine whether histologic inflammation (HI) in initial and repeat prostate biopsy specimens was significantly associated with the detection of prostate cancer. Materials and Methods Between 2005 and 2017, the clinicopathological rec...
ORIGINAL ARTICLE 2018 October 2
Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Purpose Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone administered every 3 weeks (R-CHOP-21) is the standard care for diffuse large B-cell lymphoma (DLBCL). It is unknown whether the dose-dense R-CHOP (R-CHOP-14) could improve the outcome of the dise...
ORIGINAL ARTICLE 2018 October 4
The Health Burden of Cancer Attributable to Obesity in Korea: A Population-Based Cohort Study
Purpose Considering the health impact of obesity and cancer, it is important to estimate the burden of cancer attributable to high body mass index (BMI). Therefore, the present study attempts to measure the health burden of cancer attributable to excess BMI, according to cancer...
Current Issue
Volume 51(3); Jul 2019
Volume 51(2); April 2019
Volume 51(1); January 2019
RSS feed

This archive contains links to the full-text of all issues of Cancer Res Treat.

Current Issue
Volume 51, No 3
All Issues
Vol. 51
2019
v.51(1)
Jan 2019
v.51(2)
Apr 2019
v.51(3)
Jul 2019
Vol. 50
2018
v.50(1)
Jan 2018
v.50(2)
Apr 2018
v.50(3)
Jul 2018
v.50(4)
Oct 2018
Vol. 49
2017
v.49(1)
Jan 2017
v.49(2)
Apr 2017
v.49(3)
Jul 2017
v.49(4)
Oct 2017
Vol. 48
2016
v.48(1)
Jan 2016
v.48(2)
Apr 2016
v.48(3)
Jul 2016
v.48(4)
Oct 2016
Vol. 47
2015
v.47(1)
Jan 2015
v.47(2)
Apr 2015
v.47(3)
Jul 2015
v.47(4)
Oct 2015
Vol. 46
2014
v.46(1)
Jan 2014
v.46(2)
Apr 2014
v.46(3)
Jul 2014
v.46(4)
Oct 2014
Vol. 45
2013
v.45(1)
Mar 2013
v.45(2)
Jun 2013
v.45(3)
Sep 2013
v.45(4)
Dec 2013
Vol. 44
2012
v.44(1)
Mar 2012
v.44(2)
Jun 2012
v.44(3)
Sep 2012
v.44(4)
Dec 2012
Vol. 43
2011
v.43(1)
Mar 2011
v.43(2)
Jun 2011
v.43(3)
Sep 2011
v.43(4)
Dec 2011
Vol. 42
2010
v.42(1)
Mar 2010
v.42(2)
Jun 2010
v.42(3)
Sep 2010
v.42(4)
Dec 2010
Vol. 41
2009
v.41(1)
Mar 2009
v.41(2)
Jun 2009
v.41(3)
Sep 2009
v.41(4)
Dec 2009
Vol. 40
2008
v.40(1)
Mar 2008
v.40(2)
Jun 2008
v.40(3)
Sep 2008
v.40(4)
Dec 2008
Vol. 39
2007
v.39(1)
Mar 2007
v.39(2)
Jun 2007
v.39(3)
Sep 2007
v.39(4)
Dec 2007
Vol. 38
2006
v.38(1)
Feb 2006
v.38(2)
Apr 2006
v.38(3)
Jun 2006
v.38(4)
Dec 2006
Vol. 37
2005
v.37(1)
Feb 2005
v.37(2)
Apr 2005
v.37(3)
Jun 2005
v.37(4)
Aug 2005
v.37(5)
Oct 2005
v.37(6)
Dec 2005
Vol. 36
2004
v.36(1)
Feb 2004
v.36(2)
Apr 2004
v.36(3)
Jun 2004
v.36(4)
Aug 2004
v.36(5)
Oct 2004
v.36(6)
Dec 2004
Vol. 35
2003
v.35(1)
Feb 2003
v.35(2)
Apr 2003
v.35(3)
Jun 2003
v.35(4)
Aug 2003
v.35(5)
Oct 2003
v.35(6)
Dec 2003
Vol. 34
2002
v.34(1)
Feb 2002
v.34(2)
Apr 2002
v.34(3)
Jun 2002
v.34(4)
Aug 2002
v.34(5)
Oct 2002
v.34(6)
Dec 2002
Vol. 33
2001
v.33(3)
Jun 2001
v.33(4)
Aug 2001
v.33(5)
Oct 2001
v.33(6)
Dec 2001
Journal of the Korean Cancer Association
1966 (Vol.1 No.1) to 2001 (Vol.33 No.2)
Vol. 33
2001
v.33(1)
Feb 2001
v.33(2)
Apr 2001
Vol. 32
2000
v.32(1)
Feb 2000
v.32(2)
Apr 2000
v.32(3)
Jun 2000
v.32(4)
Aug 2000
v.32(5)
Oct 2000
v.32(6)
Dec 2000
Vol. 31
1999
v.31(1)
Feb 1999
v.31(2)
Apr 1999
v.31(3)
Jun 1999
v.31(4)
Aug 1999
v.31(5)
Oct 1999
v.31(6)
Dec 1999
Vol. 30
1998
v.30(1)
Feb 1998
v.30(2)
Apr 1998
v.30(3)
Jun 1998
v.30(4)
Aug 1998
v.30(5)
Oct 1998
v.30(6)
Dec 1998
Vol. 29
1997
v.29(1)
Feb 1997
v.29(2)
Apr 1997
v.29(3)
Jun 1997
v.29(4)
Aug 1997
v.29(5)
Oct 1997
v.29(6)
Dec 1997
Vol. 28
1996
v.28(1)
1996
v.28(2)
1996
v.28(3)
1996
v.28(4)
1996
v.28(5)
1996
v.28(6)
1996
Vol. 27
1995
v.27(1)
1995
v.27(2)
1995
v.27(3)
1995
v.27(4)
1995
v.27(5)
1995
v.27(6)
1995
Vol. 26
1994
v.26(1)
1994
v.26(2)
1994
v.26(3)
1994
v.26(4)
1994
v.26(5)
1994
v.26(6)
1994
Vol. 25
1993
v.25(1)
Feb 1993
v.25(2)
Apr 1993
v.25(3)
Jun 1993
v.25(4)
Aug 1993
v.25(5)
Oct 1993
v.25(6)
Dec 1993
Vol. 24
1992
v.24(1)
Feb 1992
v.24(2)
Apr 1992
v.24(3)
Jun 1992
v.24(4)
Aug 1992
v.24(5)
Oct 1992
v.24(6)
Dec 1992
Vol. 23
1991
v.23(1)
Mar 1991
v.23(2)
Jun 1991
v.23(3)
Sep 1991
v.23(4)
Dec 1991
Vol. 22
1990
v.22(1)
1990
v.22(2)
1990
v.22(3)
1990
Vol. 21
1989
v.21(1)
1989
v.21(2)
1989
Vol. 20
1988
v.20(1)
1988
v.20(2)
1988
Vol. 19
1987
v.19(1)
1987
v.19(2)
1987
Vol. 18
1986
v.18(1)
1986
v.18(2)
1986
Vol. 17
1985
v.17(1)
1985
v.17(2)
1985
Vol. 16
1984
v.16(1)
1984
v.16(2)
1984
Vol. 15
1983
v.15(1)
1983
Vol. 14
1982
v.14(1)
1982
Vol. 13
1981
v.13(1)
1981
Vol. 12
1980
v.12(1)
1980
Vol. 11
1979
v.11(1)
1979
Vol. 10
1975
v.10(1)
1975
Vol. 8
1973
v.8(1)
1973
Vol. 7
1972
v.7(1)
1972
Vol. 6
1971
v.6(2)
1971
Vol. 5
1970
v.5(1)
1970
v.5(2)
1970
Vol. 4
1969
v.4(1)
1969
Vol. 3
1968
v.3(1)
1968
v.3(2)
1968
Vol. 2
1967
v.2(1)
1967
v.2(2)
1967
Vol. 1
1966
v.1(1)
1966
v.1(2)
1966
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Cancer Research and Treatment 2017; 49(4): 915-926.
Impact factor
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2Community